All Stories

  1. Interoceptive accuracy mediates the longitudinal relationship between attention deficit hyperactivity disorder (ADHD) inattentive symptoms and disordered eating in a community sample

    Article • Physiology & Behavior, September 2023, Elsevier

    Dr Colin Dourish

  2. The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study

    Article • Translational Psychiatry, January 2022, Springer Science + Business Media

    Dr Colin Dourish

  3. Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder

    Article • European Neuropsychopharmacology, December 2021, Elsevier

    Dr Colin Dourish

  4. The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial

    Article • Neuropsychopharmacology, February 2021, Springer Science + Business Media

    Dr Colin Dourish

  5. Associations between inattention and impulsivity ADHD symptoms and disordered eating risk in a community sample of young adults

    Article • Psychological Medicine, December 2020, Cambridge University Press

    Dr Colin Dourish

  6. P.316 ADHD symptoms are associated with binge eating and enhanced reward-related neural activation to food stimuli

    Article • European Neuropsychopharmacology, February 2020, Elsevier

    Dr Colin Dourish

  7. P.203 Intranasal insulin decreases palatable food intake, increases satiety and enhances positive mood in women with obesity

    Article • European Neuropsychopharmacology, February 2020, Elsevier

    Dr Colin Dourish

  8. Interoception and disordered eating: A systematic review

    Article • Neuroscience & Biobehavioral Reviews, December 2019, Elsevier

    Dr Colin Dourish

  9. P.048 Results of the predict randomised controlled trial: clinical effects of using the predict test to guide antidepressant treatment in depression

    Article • European Neuropsychopharmacology, December 2019, Elsevier

    Dr Colin Dourish

  10. Value of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: a modelling study

    Article • Evidence-Based Mental Health, September 2019, BMJ

    Dr Colin Dourish

  11. T108. AUT00206, A NOVEL KV3 CHANNEL MODULATOR, REDUCES KETAMINE-INDUCED BOLD SIGNALLING IN HEALTHY MALE VOLUNTEERS: A RANDOMISED PLACEBO-CONTROLLED CROSSOVER TRIAL

    Article • Schizophrenia Bulletin, April 2019, Oxford University Press (OUP)

    Dr Colin Dourish

  12. Top-down guidance of attention to food cues is enhanced in individuals with overweight/obesity and predicts change in weight at one-year follow up

    Article • International Journal of Obesity, November 2018, Springer Science + Business Media

    Dr Colin Dourish

  13. Predicting treatment response to antidepressant medication using early changes in emotional processing

    Article • European Neuropsychopharmacology, November 2018, Elsevier

    Dr Colin Dourish

  14. Associations Between Core Symptoms of Attention Deficit Hyperactivity Disorder and Both Binge and Restrictive Eating

    Article • Frontiers in Psychiatry, March 2018, Frontiers

    Dr Colin Dourish

  15. The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial

    Article • Trials, November 2017, Springer Science + Business Media

    Dr Colin Dourish

  16. Multidisciplinary approaches to the study of eating disorders and obesity: Recent progress in research and development and future prospects

    Article • Journal of Psychopharmacology, November 2017, SAGE Publications

    Dr Colin Dourish

  17. The 5-HT2C receptor agonist meta-chlorophenylpiperazine (mCPP) reduces palatable food consumption and BOLD fMRI responses to food images in healthy female volunteers

    Article • Psychopharmacology, October 2017, Springer Science + Business Media

    Dr Colin Dourish

  18. Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies

    Article • Journal of Psychopharmacology, October 2017, SAGE Publications

    Dr Colin Dourish

  19. Attention Deficit Hyperactivity Disorder (ADHD) and disordered eating behaviour: A systematic review and a framework for future research

    Article • Clinical Psychology Review, April 2017, Elsevier

    Dr Colin Dourish

  20. The relationship between attention deficit hyperactivity disorder (ADHD) and disordered eating

    Article • Appetite, December 2016, Elsevier

    Dr Colin Dourish

  21. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate

    Article • European Neuropsychopharmacology, June 2016, Elsevier

    Dr Colin Dourish

  22. Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies

    Article • Translational Psychiatry, May 2016, Springer Science + Business Media

    Dr Colin Dourish

  23. Test–retest reliability and effects of repeated testing and satiety on performance of an Emotional Test Battery

    Article • Journal of Clinical and Experimental Neuropsychology, December 2015, Taylor & Francis

    Dr Colin Dourish

  24. Effects of awareness that food intake is being measured by a universal eating monitor on the consumption of a pasta lunch and a cookie snack in healthy female volunteers

    Article • Appetite, September 2015, Elsevier

    Dr Colin Dourish

  25. P.2.f.013 A precision medicine approach to antidepressant treatment in depression

    Article • European Neuropsychopharmacology, September 2015, Elsevier

    Dr Colin Dourish

  26. Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI

    Article • Aging Neuropsychology and Cognition, August 2015, Taylor & Francis

    Dr Colin Dourish

  27. Satiation attenuates BOLD activity in brain regions involved in reward and increases activity in dorsolateral prefrontal cortex: an fMRI study in healthy volunteers

    Article • American Journal of Clinical Nutrition, January 2015, Oxford University Press (OUP)

    Dr Colin Dourish

  28. Alterations in working memory networks in amnestic mild cognitive impairment

    Article • Aging Neuropsychology and Cognition, March 2014, Taylor & Francis

    Dr Colin Dourish

  29. Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers

    Article • Psychopharmacology, January 2014, Springer Science + Business Media

    Dr Colin Dourish

  30. Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia

    Article • Biomarkers in Medicine, January 2014, Future Medicine

    Dr Colin Dourish

  31. Monitoring eating behaviour in the laboratory. Do we need to do it covertly?

    Article • Appetite, December 2013, Elsevier

    Dr Colin Dourish

  32. The effects of ketamine and risperidone on eye movement control in healthy volunteers

    Article • Translational Psychiatry, December 2013, Springer Science + Business Media

    Dr Colin Dourish

  33. S.1.4 - DRUGS FOR OBESITY

    Article • Behavioural Pharmacology, October 2013, Wolters Kluwer Health

    Dr Colin Dourish

  34. G.9 - EFFECT OF META-CHLOROPHENYLPIPERAZINE (MCPP) ON APPETITE, SATIETY AND FMRI BOLD SIGNAL IN HEALTHY VOLUNTEERS

    Article • Behavioural Pharmacology, October 2013, Wolters Kluwer Health

    Dr Colin Dourish

  35. Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate

    Article • Human Psychopharmacology Clinical and Experimental, August 2013, Wiley

    Dr Colin Dourish

  36. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy

    Article • Psychopharmacology, February 2013, Springer Science + Business Media

    Dr Colin Dourish

  37. Combined NK1 antagonism and serotonin reuptake inhibition: effects on emotional processing in humans

    Article • Journal of Psychopharmacology, February 2013, SAGE Publications

    Dr Colin Dourish

  38. Differential effect of amisulpride on cognition in schizotypy: validation of models for the early identification of cognitive enhancing agents

    Article • The Lancet, February 2013, Elsevier

    Dr Colin Dourish

  39. Neuroimaging Approaches to the Understanding of Depression and the Identification of Novel Antidepressants

    Article • January 2013, Elsevier

    Dr Colin Dourish

  40. The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety

    Article • Human Psychopharmacology Clinical and Experimental, October 2012, Wiley

    Dr Colin Dourish

  41. P.2.c.024 PharmacoMRI and cognitive effects of the potential antidepressant AZD6765 compared with ketamine in untreated major depressive disorder

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Dr Colin Dourish

  42. A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: A three-center double-blind placebo-controlled study

    Article • European Neuropsychopharmacology, July 2012, Elsevier

    Dr Colin Dourish

  43. Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic

    Article • Journal of Psychopharmacology, April 2012, SAGE Publications

    Dr Colin Dourish

  44. Friday Abstracts

    Article • Biological Psychiatry, April 2012, Elsevier

    Jean Theberge, Dr Colin Dourish

  45. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy

    Article • Pharmacopsychiatry, September 2011, Thieme Publishing Group

    Dr Colin Dourish

  46. Special issue on CNS experimental medicine

    Article • Journal of Psychopharmacology, September 2011, SAGE Publications

    Dr Colin Dourish

  47. Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)

    Article • Journal of Psychopharmacology, September 2011, SAGE Publications

    Dr Colin Dourish

  48. Validation of experimental medicine methods in psychiatry: The P1vital approach and experience

    Article • Biochemical Pharmacology, June 2011, Elsevier

    Dr Colin Dourish

  49. Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety

    Article • Journal of Psychopharmacology, May 2011, SAGE Publications

    Dr Colin Dourish

  50. P.4.010 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy

    Article • European Neuropsychopharmacology, March 2011, Elsevier

    Dr Colin Dourish

  51. P.2.c.021 Agomelatine facilitates positive emotional processing in healthy volunteers

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Dr Colin Dourish

  52. Agomelatine facilitates positive versus negative affective processing in healthy volunteer models

    Article • Journal of Psychopharmacology, July 2010, SAGE Publications

    Dr Colin Dourish

  53. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women

    Article • Journal of Psychopharmacology, August 2008, SAGE Publications

    Dr Colin Dourish

  54. P.4.c.003 Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Dr Colin Dourish

  55. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, May 2008, Elsevier

    Dr Colin Dourish

  56. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, May 2008, Elsevier

    Dr Colin Dourish

  57. Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines

    Article • Bioorganic & Medicinal Chemistry Letters, May 2008, Elsevier

    Dr Colin Dourish

  58. Anti-obesity Drugs: From Animal Models to Clinical Efficacy

    Article • January 2008, Elsevier

    Dr Colin Dourish

  59. Synthesis and biological evaluation of novel hexahydro-pyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT2C receptor agonists

    Article • Bioorganic & Medicinal Chemistry Letters, March 2006, Elsevier

    Dr Colin Dourish

  60. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse

    Article • Psychopharmacology, February 2006, Springer Science + Business Media

    Dr Colin Dourish

  61. Pyrrolo(iso)quinoline derivatives as 5-HT2C receptor agonists

    Article • Bioorganic & Medicinal Chemistry Letters, February 2006, Elsevier

    Dr Colin Dourish

  62. Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists

    Article • Bioorganic & Medicinal Chemistry Letters, August 2005, Elsevier

    Dr Colin Dourish

  63. Tonic regulation of satiety by 5-HT1B receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies?

    Article • European Journal of Neuroscience, June 2004, Wiley

    Dr Colin Dourish

  64. Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice

    Article • Psychopharmacology, May 2004, Springer Science + Business Media

    Dr Colin Dourish

  65. Indoline derivatives as 5-HT 2C receptor agonists

    Article • Bioorganic & Medicinal Chemistry Letters, May 2004, Elsevier

    Dr Colin Dourish

  66. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes

    Article • Neuropharmacology, April 2004, Elsevier

    Dr Colin Dourish

  67. Company founders: voices of experience

    Article • Bioentrepreneur, March 2004, Springer Science + Business Media

    Dr Colin Dourish

  68. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease

    Article • Neurology, December 2003, Wolters Kluwer Health

    Dr Colin Dourish

  69. Potential for antipsychotic and psychotomimetic effects of A2A receptor modulation

    Article • Neurology, December 2003, Wolters Kluwer Health

    Dr Colin Dourish

  70. Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia

    Article • Psychopharmacology, April 2003, Springer Science + Business Media

    Dr Colin Dourish

  71. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats

    Article • Psychopharmacology, March 2003, Springer Science + Business Media

    Dr Colin Dourish

  72. 5-HT1Breceptor knockout mice show a compensatory reduction in 5-HT2Creceptor function

    Article • European Journal of Neuroscience, January 2003, Wiley

    Dr Colin Dourish

  73. 5-HT 1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin 1B agonist CP-94,253

    Article • Psychopharmacology, October 2002, Springer Science + Business Media

    Dr Colin Dourish

  74. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice

    Article • Pharmacology Biochemistry and Behavior, April 2002, Elsevier

    Dr Colin Dourish

  75. Preface

    Article • Neuromodulation Technology at the Neural Interface, October 2001, Wiley

    Professor Jawad K. Ali, Dr Colin Dourish

  76. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors

    Article • Neuropharmacology, August 2001, Elsevier

    Dr Colin Dourish

  77. Case Series: Amantadine Open-Label Treatment of Impulsive and Aggressive Behavior in Hospitalized Children With Developmental Disabilities

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, June 2001, Elsevier

    Dr Colin Dourish

  78. Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, June 2001, Elsevier

    Dr Colin Dourish

  79. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat

    Article • Psychopharmacology, August 2000, Springer Science + Business Media

    Dr Colin Dourish

  80. Comparative effects of continuous infusion ofmCPP, Ro 60-0175 andd-fenfluramine on food intake, water intake, body weight and locomotor activity in rats

    Article • British Journal of Pharmacology, July 2000, Wiley

    Dr Colin Dourish

  81. Measurement of Anxiety in Transgenic Mice

    Article • Reviews in the Neurosciences, January 2000, De Gruyter

    Dr Colin Dourish

  82. 5-HT2C receptor modulation and the treatment of obesity

    Article • Diabetes Obesity and Metabolism, July 1999, Wiley

    Dr Colin Dourish

  83. Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

    Article • Psychopharmacology, April 1999, Springer Science + Business Media

    Dr Colin Dourish

  84. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety

    Article • Neuroscience & Biobehavioral Reviews, December 1998, Elsevier

    Dr Colin Dourish

  85. Blockade of pre-and post-synaptic 5-HT 1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats

    Article • Psychopharmacology, November 1997, Springer Science + Business Media

    Dr Colin Dourish

  86. WAY100635 and latent inhibition in the rat: selective effects at preexposure

    Article • Behavioural Brain Research, October 1997, Elsevier

    Dr Colin Dourish

  87. Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats

    Article • Psychopharmacology, September 1997, Springer Science + Business Media

    Dr Colin Dourish

  88. Devazepide Attenuates dl-Fenfluramine-Induced Suppression of Gastric Emptying but Not Food Intake in the 17 h Food-Deprived Rat

    Article • Physiology & Behavior, September 1997, Elsevier

    Dr Colin Dourish

  89. Child and learning disability psychopharmacology

    Article • Journal of Psychopharmacology, July 1997, SAGE Publications

    Dr Colin Dourish

  90. Effects of 5-HT 1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat

    Article • Psychopharmacology, December 1996, Springer Science + Business Media

    Dr Colin Dourish

  91. Lack of Interaction Between Devazepide and 8-OH-DPAT-Induced Hyperphagia in the Rat

    Article • Physiology & Behavior, November 1996, Elsevier

    Dr Colin Dourish

  92. Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory

    Article • Psychopharmacology, August 1996, Springer Science + Business Media

    Dr Colin Dourish

  93. Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype

    Article • Psychopharmacology, May 1996, Springer Science + Business Media

    Dr Colin Dourish

  94. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists

    Article • Psychopharmacology, December 1995, Springer Science + Business Media

    Dr Colin Dourish

  95. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

    Article • Behavioural Brain Research, December 1995, Elsevier

    Dr Colin Dourish

  96. Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?

    Article • Obesity Research, November 1995, Wiley

    Dr Colin Dourish

  97. Benefits of ethological analysis of behaviour

    Article • Trends in Pharmacological Sciences, August 1995, Elsevier

    Dr Colin Dourish

  98. Analysis of glutamate in striatal microdialysates using capillary electrophoresis and laser-induced fluorescence detection

    Article • Journal of Chromatography A, May 1995, Elsevier

    Dr Colin Dourish

  99. Comparisons between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat

    Article • Pharmacology Biochemistry and Behavior, April 1995, Elsevier

    Dr Colin Dourish

  100. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190

    Article • European Journal of Pharmacology, April 1995, Elsevier

    Dr Colin Dourish

  101. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze

    Article • European Journal of Pharmacology, December 1994, Elsevier

    Dr Colin Dourish

  102. Implications of Eshkol-Wachman movement notation for behavioural pharmacology

    Article • Behavioral and Brain Sciences, December 1994, Cambridge University Press

    Dr Colin Dourish

  103. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635

    Article • European Journal of Pharmacology, October 1994, Elsevier

    Dr Colin Dourish

  104. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety

    Article • Psychopharmacology, September 1994, Springer Science + Business Media

    Dr Colin Dourish

  105. Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats

    Article • European Journal of Pharmacology, March 1994, Elsevier

    Dr Colin Dourish

  106. In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function

    Article • Neuropharmacology, March 1994, Elsevier

    Dr Colin Dourish

  107. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat

    Article • Neuroscience, February 1994, Elsevier

    Dr Colin Dourish

  108. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats

    Article • Psychopharmacology, January 1994, Springer Science + Business Media

    Dr Colin Dourish

  109. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents

    Article • Trends in Pharmacological Sciences, December 1993, Elsevier

    Dr Colin Dourish

  110. The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice

    Article • Physiology & Behavior, October 1993, Elsevier

    Dr Colin Dourish

  111. Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study

    Article • European Journal of Pharmacology, August 1993, Elsevier

    Dr Colin Dourish

  112. Na+ channels

    Article • Trends in Pharmacological Sciences, January 1993, Elsevier

    Dr Colin Dourish

  113. The effects of 5-HT and dl-fenfluramine on gastric emptying and food intake in fasted rats

    Article • Appetite, October 1992, Elsevier

    Dr Colin Dourish

  114. Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat

    Article • European Journal of Pharmacology, August 1992, Elsevier

    Dr Colin Dourish

  115. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19

    Article • European Journal of Pharmacology, January 1992, Elsevier

    Dr Colin Dourish

  116. L-683,877: Pharmacological profile of a novel 5-HT3 receptor antagonist

    Article • Drug Development Research, January 1992, Wiley

    Dr Colin Dourish

  117. CCK antagonists and CCK-monoamine interactions in the control of satiety

    Article • American Journal of Clinical Nutrition, January 1992, Elsevier

    Dr Colin Dourish

  118. Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications

    Article • Biochemical Society Transactions, November 1991, Portland Press Ltd.

    Dr Colin Dourish

  119. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats

    Article • Psychopharmacology, September 1991, Springer Science + Business Media

    Dr Colin Dourish

  120. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260

    Article • European Journal of Pharmacology, February 1991, Elsevier

    Dr Colin Dourish

  121. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding

    Article • Physiology & Behavior, December 1990, Elsevier

    Dr Colin Dourish

  122. Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey

    Article • Brain Research, November 1990, Elsevier

    Dr Colin Dourish

  123. Cholecystokinin and anxiety

    Article • Trends in Pharmacological Sciences, July 1990, Elsevier

    Dr Colin Dourish

  124. The anti-emetic action of the novel 5-HT3 receptor antagonist L-683,877 in the ferret

    Article • European Journal of Pharmacology, July 1990, Elsevier

    Dr Colin Dourish

  125. Pharmacological characterization of the behavioral syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT

    Article • Brain Research, May 1990, Elsevier

    A Jon Stoessl, Dr Colin Dourish

  126. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329

    Article • British Journal of Pharmacology, January 1990, Wiley

    Dr Colin Dourish

  127. Fluoxetine reduces food intake by a cholecystokinin-independent mechanism

    Article • Pharmacology Biochemistry and Behavior, January 1990, Elsevier

    Dr Colin Dourish

  128. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

    Article • European Journal of Pharmacology, January 1990, Elsevier

    Dr Colin Dourish

  129. The role of CCK, caerulein, and CCK antagonists in nociception

    Article • Pain, December 1989, Wolters Kluwer Health

    Dr Colin Dourish

  130. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76

    Article • Neuropharmacology, December 1989, Elsevier

    Dr Colin Dourish

  131. Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors

    Article • European Journal of Pharmacology, December 1989, Elsevier

    Dr Colin Dourish

  132. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype

    Article • Neuroscience Letters, October 1989, Elsevier

    Dr Colin Dourish

  133. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors

    Article • Science, September 1989, American Association for the Advancement of Science

    Dr Colin Dourish

  134. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy

    Article • Brain Research, August 1989, Elsevier

    A Jon Stoessl, Dr Colin Dourish

  135. Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists

    Article • Psychopharmacology, July 1989, Springer Science + Business Media

    A Jon Stoessl, Dr Colin Dourish

  136. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329

    Article • Neuropharmacology, March 1989, Elsevier

    Dr Colin Dourish

  137. The role of 5-HTB receptors in the paraventricular nucleus of the hypothalamus in the control of feeding

    Article • Neurobiology of Aging, March 1989, Elsevier

    Dr Colin Dourish

  138. Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats

    Article • Psychopharmacology, January 1989, Springer Science + Business Media

    Dr Colin Dourish

  139. Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats

    Article • Psychopharmacology, November 1988, Springer Science + Business Media

    Dr Colin Dourish

  140. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation

    Article • Psychopharmacology, August 1988, Springer Science + Business Media

    A Jon Stoessl, Dr Colin Dourish

  141. Antinociceptive effects of novel, selective tachykinin receptor antagonists in thermal and chemical analgesia tests

    Article • Regulatory Peptides, July 1988, Elsevier

    Dr Colin Dourish

  142. Behavioural evidence for CNS tachykinin-cholinergic interactions

    Article • Regulatory Peptides, July 1988, Elsevier

    Dr Colin Dourish

  143. Pharmacological characterization of central tachykinin: 5-HT interactions

    Article • Regulatory Peptides, July 1988, Elsevier

    Dr Colin Dourish

  144. The role of NK-3 and NK-4 receptors in the mediation of reciprocal hindlimb scratching induced by tachykinin receptor agonists

    Article • Regulatory Peptides, July 1988, Elsevier

    Dr Colin Dourish

  145. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats

    Article • British Journal of Pharmacology, June 1988, Wiley

    A Jon Stoessl, Dr Colin Dourish

  146. 8-OH-DPAT elicits feeding and not chewing: evidence from liquid diet studies and a diet choice test

    Article • Psychopharmacology, June 1988, Springer Science + Business Media

    Dr Colin Dourish

  147. CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic location

    Article • Brain Research, June 1988, Elsevier

    Dr Colin Dourish

  148. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors

    Article • European Journal of Pharmacology, June 1988, Elsevier

    Dr Colin Dourish

  149. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718

    Article • European Journal of Pharmacology, March 1988, Elsevier

    Dr Colin Dourish

  150. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats

    Article • Psychoneuroendocrinology, January 1988, Elsevier

    Dr Colin Dourish

  151. The 5-HT1A agonist 8-OH-DPAT increases consumption of palatable wet mash and liquid diets in the rat

    Article • Psychopharmacology, January 1988, Springer Science + Business Media

    Dr Colin Dourish

  152. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra

    Article • Psychopharmacology, November 1987, Springer Science + Business Media

    A Jon Stoessl, Dr Colin Dourish

  153. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT

    Article • Psychopharmacology, November 1987, Springer Science + Business Media

    Dr Colin Dourish

  154. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse

    Article • Neuroscience Letters, October 1987, Elsevier

    A Jon Stoessl, Dr Colin Dourish

  155. 5-HT1B agonists induce anorexia at a postsynaptic site

    Article • European Journal of Pharmacology, September 1987, Elsevier

    Dr Colin Dourish

  156. Classification and function of CCK receptors

    Article • Trends in Pharmacological Sciences, June 1987, Elsevier

    Dr Colin Dourish

  157. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action

    Article • European Journal of Pharmacology, June 1987, Elsevier

    Dr Colin Dourish

  158. Experimental Psychopharmacology

    Article • April 1987, Springer Science + Business Media

    Dr Colin Dourish

  159. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression

    Article • European Journal of Pharmacology, February 1987, Elsevier

    Dr Colin Dourish

  160. Effects of Drugs on Spontaneous Motor Activity

    Article • January 1987, Springer Science + Business Media

    Dr Colin Dourish

  161. The 5-HT1A agonists 8-OH-DPAT, buspirone and ipsapirone attenuate stress-induced anorexia in rats

    Article • Journal of Psychopharmacology, January 1987, SAGE Publications

    Dr Colin Dourish

  162. Monitoring 5HT Metabolism in the Brain of the Freely Moving Rat

    Article • Annals of the New York Academy of Sciences, December 1986, Wiley

    Dr Colin Dourish

  163. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors

    Article • European Journal of Pharmacology, October 1986, Elsevier

    Dr Colin Dourish

  164. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)

    Article • Psychopharmacology, July 1986, Springer Science + Business Media

    Dr Colin Dourish

  165. 8-OH-DPAT-induced hyperphagia: Its neural basis and possible therapeutic relevance

    Article • Appetite, January 1986, Elsevier

    Dr Colin Dourish

  166. Pustative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphé nuclei

    Article • Trends in Pharmacological Sciences, January 1986, Elsevier

    Dr Colin Dourish

  167. Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats

    Article • Neuropharmacology, November 1985, Elsevier

    Dr Colin Dourish

  168. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)

    Article • Brain Research Bulletin, October 1985, Elsevier

    Dr Colin Dourish

  169. Pharmacological and biochemical analysis of feeding behaviour

    Article • Brain Research Bulletin, October 1985, Elsevier

    Dr Colin Dourish

  170. Preface

    Article • Brain Research Bulletin, October 1985, Elsevier

    Dr Colin Dourish

  171. Preface

    Article • Estuaries, June 1985, Springer Science + Business Media

    Dr Colin Dourish

  172. Behavioural evidence for the existence of dopamine autoreceptors

    Article • Trends in Pharmacological Sciences, January 1985, Elsevier

    Dr Colin Dourish

  173. Local application of β-phenylethylamine to the caudate nucleus of the rat elicits locomotor stimulation

    Article • Pharmacology Biochemistry and Behavior, January 1985, Elsevier

    Dr Colin Dourish

  174. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat

    Article • Psychopharmacology, January 1985, Springer Science + Business Media

    Dr Colin Dourish

  175. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat

    Article • Psychopharmacology, January 1985, Springer Science + Business Media

    Dr Colin Dourish

  176. Environmental experience produces qualitative changes in the stimulant effects of ?-phenylethylamine in rats

    Article • Psychopharmacology, September 1984, Springer Science + Business Media

    Dr Colin Dourish

  177. Potentiation of total horizontal activity and ambulation in rats treated with combinations of β-phenylethylamine and naloxone

    Article • Neuropharmacology, September 1984, Elsevier

    Dr Colin Dourish

  178. Locomotor Stimulant Effect of β-Phenylethylamine-Naloxone Mixtures

    Article • January 1984, Springer Science + Business Media

    Dr Colin Dourish

  179. Effects of Tryptamine and 5-Hydroxytryptamine on Food Intake in the Rat

    Article • January 1984, Springer Science + Business Media

    Dr Colin Dourish

  180. Differential aversive stimulus properties of ?-phenylethylamine and of d-amphetamine

    Article • Psychopharmacology, January 1984, Springer Science + Business Media

    Dr Colin Dourish

  181. Effects of piribedil and of d-amphetamine on locomotor activity in immature rats

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1984, Elsevier

    Dr Colin Dourish

  182. Hypodipsia, stereotypy and hyperactivity induced by β-phenylethylamine in the water-deprived rat

    Article • Pharmacology Biochemistry and Behavior, January 1984, Elsevier

    Dr Colin Dourish

  183. Deuterium substitution enhances the effects of β-phenylethylamine on spontaneous motor activity in the rat

    Article • Pharmacology Biochemistry and Behavior, September 1983, Elsevier

    Dr Colin Dourish

  184. Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution

    Article • Psychopharmacology, September 1983, Springer Science + Business Media

    Dr Colin Dourish

  185. Dopaminergic involvement in the control of drinking behaviour: A brief review

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1983, Elsevier

    Dr Colin Dourish

  186. Pharmacology of β-phenylethylamine-induced seizures in mice

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1983, Elsevier

    Dr Colin Dourish

  187. Piribedil: Behavioural, neurochemical and clinical profile of a dopamine agonist

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1983, Elsevier

    Dr Colin Dourish

  188. Putative PEA receptors?

    Article • Psychiatry Research, December 1982, Elsevier

    Dr Colin Dourish

  189. Alterations in trace amine and trace acid concentrations in isolated aggressive mice

    Article • Pharmacology Biochemistry and Behavior, December 1982, Elsevier

    Dr Colin Dourish

  190. The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat

    Article • European Journal of Pharmacology, October 1982, Elsevier

    Dr Colin Dourish

  191. A PHARMACOLOGICAL ANALYSIS OF THE HYPERACTIVITY SYNDROME INDUCED BY β-PHENYLETHYLAMINE IN THE MOUSE

    Article • British Journal of Pharmacology, September 1982, Wiley

    Dr Colin Dourish

  192. Variation in response to stimulation of central 5-hydroxytryptamine mechanisms in two strains of albino rat

    Article • Brain Research, September 1982, Elsevier

    Dr Colin Dourish

  193. Dopamine agonist-induced restoration of drinking in response to hypertonie saline in adipsic dopamine denervated rats

    Article • Brain Research Bulletin, April 1982, Elsevier

    Dr Colin Dourish

  194. An observational analysis of the behavioural effects of β-Phenylethylamine in isolated and grouped mice

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1982, Elsevier

    Dr Colin Dourish

  195. Behavioural and neurochemical effects of meta-tyrosine in the rat

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1982, Elsevier

    Dr Colin Dourish

  196. Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1982, Elsevier

    Dr Colin Dourish

  197. Suppression of drinking and induction of sedation by a dopamine agonists is blocked by small doses of spiperone

    Article • Neuropharmacology, January 1982, Elsevier

    Dr Colin Dourish

  198. Behavioural effects of acute and chronic β-phenylethylamine administration in the rat: Evidence for the involvement of 5-hydroxytryptamine

    Article • Neuropharmacology, November 1981, Elsevier

    Dr Colin Dourish

  199. Single or repeated administration of small doses of apomorphine on water intake and activity in water-deprived rats

    Article • Neuropharmacology, March 1981, Elsevier

    Dr Colin Dourish

  200. Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat

    Article • Psychopharmacology, January 1981, Springer Science + Business Media

    Dr Colin Dourish

  201. The effects of acute and chronic administration of β-phenylethylamine on food intake and body weight in rats

    Article • Progress in Neuro-Psychopharmacology, January 1981, Elsevier

    Dr Colin Dourish

  202. Effects of et 495 (piribedil) on water intake in the rat: Evidence for a dopaminergic involvement in thirst

    Article • Irish Journal of Medical Science (1971 -), December 1978, Springer Science + Business Media

    Dr Colin Dourish

  203. Effects of Drugs on Spontaneous Motor Activity

    Article • Springer Science + Business Media

    Dr Colin Dourish